IQV · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $16.31B | $15.40B | $14.98B | $14.41B | $13.87B | $11.36B | $11.09B | $10.41B |
| Selling, General & Administrative | $2.00B | $1.99B | $2.05B | $2.07B | $1.96B | $1.79B | $1.73B | $1.72B |
| Operating Income | $2.18B | $2.20B | $1.98B | $1.80B | $1.39B | $731.00M | $777.00M | $741.00M |
| Interest Expense | $729.00M | $670.00M | $672.00M | $416.00M | $375.00M | $416.00M | $447.00M | $414.00M |
| Other Income / (Expense) | $99.00M | $90.00M | $124.00M | -$33.00M | $130.00M | $65.00M | $37.00M | -$5.00M |
| Income Before Taxes | $1.59B | $1.67B | $1.46B | $1.36B | $1.13B | $373.00M | $352.00M | $328.00M |
| Provision for Income Taxes | $252.00M | $301.00M | $101.00M | $260.00M | $163.00M | $72.00M | $116.00M | $59.00M |
| Net Income | $1.36B | $1.37B | $1.36B | $1.09B | $966.00M | $279.00M | $191.00M | $259.00M |
| Basic EPS | $7.91 | $7.57 | $7.39 | $5.82 | $5.05 | $1.46 | $0.98 | $1.27 |
| Diluted EPS | $7.84 | $7.49 | $7.29 | $5.72 | $4.95 | $1.43 | $0.96 | $1.24 |
| Basic Shares Outstanding | 171.90M | 181.30M | 183.80M | 187.60M | 191.40M | 191.30M | 195.10M | 203.70M |
| Diluted Shares Outstanding | 173.50M | 183.40M | 186.30M | 190.60M | 195.00M | 195.00M | 199.60M | 208.20M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $11.57 | $11.42 | $11.73 | 9 | ↑1 ↓2 |
| Dec 2027 | $12.92 | $12.45 | $13.50 | 9 | ↑2 ↓2 |
| Dec 2028 | $14.57 | $14.40 | $14.69 | 3 | ↑1 ↓0 |